Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

Stock Information for Chiasma Inc.

Loading

Please wait while we load your information from QuoteMedia.